WaferGen Biosystems

Biotechnology, Genetics, Life Science, Pharmaceutical
Founded in 2002-01-01
Fremont, California, United States
For Profit

About WaferGen Biosystems

WaferGen Bio-systems, Inc. is an emerging genomic analysis company in the early stage of commercialization. The company offers the transformative SmartChip Real-Time PCR System—a next-generation Real-Time PCR System for profiling and validation of gene expression patterns (biomarkers) on a single platform. The SmartChip System provides a range of high-throughput capabilities including microRNA and mRNA gene expression profiling and single nucleotide polymorphism (SNP) genotyping.

Company Metrics

  • Employees: 51-100
  • Monthly Visits: None
  • Tech Stack: 12 active products

Financial Information

  • Estimated Revenue: $10M to $50M
  • Total Funding: 86896750 USD
  • Last Funding: 15000000 USD (Post-IPO Equity)
  • Funding Status: M&A

Technology Stack

WaferGen Biosystems actively uses 12 products in their tech stack.

Market Presence

Industries: Biotechnology, Genetics, Life Science, Pharmaceutical

Headquarters: Fremont, California, United States